FDA Inspection 1070841 — Samuel A. Mujica Trenche, MD
The FDA completed an inspection of Samuel A. Mujica Trenche, MD on April 20, 2018 in Henderson, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Henderson, NV (United States)
Additional Details
Clinical Investigator (CI)